MarketFriction

NGL Fine Chem Ltd

NSE NGLFINE · BSE 524774 · Pharmaceuticals
₹2,924.00 +0.50%
NSE close2026-10-01
52 week range1,271.00 - 3,602.00
Market cap₹1,774 Cr.
P/E35.2
Price band 20% Delivery 35.9%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue from operations79859688918793101117126145137
Operating costs6674838281838993103106127117
EBITDA13111361144814201820
EBITDA margin %17%13%13%7%12%4.1%4.2%8%12%16%12%14%
Depreciation & amortisation222222334444
Finance costs000001111111
Non-operating income444650-172537
Pre-tax profit15131410131-01011191522
Effective tax rate %24%30%24%22%25%4%44%21%26%24%24%24%
Profit after tax119118101-188151116
Earnings per share (Rs)17.7614.4117.5612.6716.251.26-0.8412.3712.7923.8618.3726.63
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue from operations96100114153152258319275329359489525
Operating costs747492121129181253246284332421454
EBITDA222522322377662945276871
EBITDA margin %23%26%19%21%15%30%21%10%14%7%14%14%
Depreciation & amortisation33567788891617
Finance costs212332222354
Non-operating income0134191381610817
Pre-tax profit182318281476692751245567
Effective tax rate %36%35%29%27%26%27%24%24%24%24%24%
Profit after tax111513201155522039184250
Earnings per share (Rs)18.4524.1020.3832.5817.1689.7984.5732.5762.3529.3567.3881.65
Paid out as dividend %-0%-0%-0%5%10%2%2%5%3%6%3%
10 Years5 Years3 YearsTTM1 YearLast Year
Revenue CAGR18%14%21%41%
Profit CAGR15%-3%32%181%
Share price CAGR24%1%14%103%
Average return on equity18%15%13%16%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Net block (property, plant)17242556616158595960120144
Capital work in progress12163-0-01626465095
Investments2366914333243576343
Current & other assets464955637380115180159190193248
Total assets6778102129142156206278288353426530
Share capital333333333333
Reserves & surplus304156698998152203222260277317
Total debt1314232727281630323477122
Other liabilities & provisions211920312326344130567088
Equity + liabilities6778102129142156206278288353426530
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating cash flow881022920271332112235
Investing cash flow-3-10-10-21-10-19-24-13-24-17-58-65
Free cash flow (after capex)5-2-8-1-61222-23-17-51-51
Financing cash flow-42-0-0-0-1-1-1-1-13630
Net change in cash10-01-1-02-17-700
Cash conversion (OCF / EBITDA) %80%68%70%128%50%101%61%45%134%52%104%70%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Return on capital employed %29%37%34%22%28%15%52%35%12%19%8%17%
Receivable days107123110897963537486928194
Inventory days10690114134106154132133699995101
Payable days150122139187921149484591109489
Cash cycle (days)639185359310391124978283106
Working capital days384945187063718967715159
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoter group %73.06%73.06%72.74%72.74%72.74%72.74%72.74%72.74%72.74%72.74%72.73%72.49%
Foreign investors %0.02%0.04%0.10%0.03%0.02%0.05%0.00%0.00%0.00%0.00%0.03%0.05%
Domestic institutions %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.02%
Retail & others %26.93%26.91%27.16%27.24%27.25%27.23%27.26%27.26%27.26%27.26%27.23%27.43%
Shareholder count17,62316,41015,04114,60814,57514,11014,38614,01013,38712,83412,51613,393

Fundamentals

Market value₹ 1,774 Cr.
Last price₹ 2,871
P/E (trailing)35.2
Book value / share₹ 518
Return on capital16.7 %
Return on equity15.6 %
Dividend yield0.06 %
Face value₹ 5.00
Revenue CAGR (TTM)41%
Profit CAGR (TTM)181%
Standalone figures.
Valuation
Market capRs 1,806 Cr
Enterprise valueRs 1,925 Cr
P/E (TTM)35.81x
Price to book5.65x
Price to sales3.44x
EV / EBITDA21.86x
EV / EBIT27.19x
EV / sales3.67x
Price to cash flow52.01x
Earnings yield2.79%
Dividend yield0.06%
P/E, 3-year average34.24x
P/B, 3-year average3.80x
P/E, 5-year average32.55x
P/B, 5-year average4.11x
Profitability
Operating margin (excl. other income)13.92%
Operating margin (incl. other income)15.54%
EBITDA margin16.79%
Pre-tax margin12.70%
Net profit margin9.61%
Net margin, latest quarter12.03%
ROE13.89%
ROCE14.95%
ROA8.71%
ROE, 3-year average12.12%
ROCE, 3-year average14.06%
ROA, 3-year average8.46%
ROE, 5-year average14.91%
ROCE, 5-year average17.68%
ROA, 5-year average10.82%
ROIC (approx.)12.30%
Tax rate23.78%
Other income / net worth2.48%
Growth
Sales growth (latest year)36.04%
Profit growth (latest year)129.62%
Sales CAGR, 3 years21.12%
Sales CAGR, 5 years13.62%
Profit CAGR, 3 years27.43%
Profit CAGR, 5 years-5.58%
Sales growth QoQ-5.55%
Profit growth QoQ44.93%
Sales growth YoY (latest quarter)35.54%
Profit growth YoY (latest quarter)115.31%
Per share
EPS (TTM)Rs 81.64
EPS (latest year)Rs 67.38
EPS (latest quarter)Rs 26.63
EPS, 3-year averageRs 53.03
EPS, 5-year averageRs 55.24
Book value per shareRs 517.87
Sales per shareRs 849.19
Cash flow per shareRs 56.22
Dividend per share (latest year)Rs 1.75
Dividend per share, 3-year averageRs 1.75
Dividend per share, 5-year averageRs 1.75
Dividends
Dividend payout2.59%
Dividend payout, 3-year average3.79%
Dividend payout, 5-year average3.76%
Efficiency
Asset turnover0.92x
Fixed asset turnover3.39x
Inventory turnover5.00x
Inventory days73 days
Debtor days94 days
Debtors turnover3.90x
Leverage
Total debtRs 122 Cr
Cash and bankRs 3 Cr
Net debtRs 119 Cr
Debt to equity0.38x
Net debt / EBITDA1.35x
Interest coverage16.98x
Current ratio (filing 2026-03-31)1.84x
Quick ratio (filing 2026-03-31)1.37x
Trade payables (filing 2026-03-31)Rs 60 Cr
Owners' fund to total sources60.41%
Debt to assets22.97%
Cash flow
Operating cash flow (latest year)Rs 35 Cr
Investing cash flow (latest year)Rs -65 Cr
Financing cash flow (latest year)Rs 30 Cr
Net change in cash (latest year)Rs 0 Cr
Sales to cash flow14.07x
Statement figures
Net sales (TTM)Rs 525 Cr
Net sales (latest year)Rs 489 Cr
Sales (latest quarter)Rs 137 Cr
Operating profit excl. other income (latest year)Rs 68 Cr
Operating profit (latest quarter)Rs 20 Cr
Other income (TTM)Rs 17 Cr
EBITDA (TTM)Rs 88 Cr
PBDT (TTM)Rs 84 Cr
Profit before tax (TTM)Rs 67 Cr
Tax (latest year)Rs 13 Cr
Net profit (TTM)Rs 50 Cr
Net profit (latest year)Rs 42 Cr
Net profit (latest quarter)Rs 16 Cr
Depreciation (TTM)Rs 17 Cr
Depreciation (latest quarter)Rs 4 Cr
Interest (TTM)Rs 4 Cr
Cost of goods sold (latest year)Rs 338 Cr
Total expenditure (latest year)Rs 421 Cr
Total income (latest year)Rs 497 Cr
Share capitalRs 3 Cr
ReservesRs 317 Cr
Shareholders' fundsRs 320 Cr
Total assetsRs 530 Cr
Net blockRs 144 Cr
Capital work in progressRs 95 Cr
InvestmentsRs 43 Cr
ReceivablesRs 125 Cr
InventoryRs 68 Cr
Other liabilitiesRs 88 Cr
Shares outstanding (crore)0.62
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 35.8 is at the 64th percentile of its own 9.4-year range (median 25.9, low 8.1, high 105.1).
P/B 5.65 is at the 74th percentile (median 4.55).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodNGLFINENifty 50Difference
1 week+1.0%-2.8% +3.8 pts
1 month+10.0%-6.8% +16.8 pts
3 months-8.8%-7.6% -1.2 pts
6 months+42.1%+0.4% +41.7 pts
1 year+106.8%-9.9% +116.7 pts
2 years+34.7%-13.6% +48.3 pts
3 years+49.1%+14.2% +35.0 pts
5 years+5.3%+27.9% -22.6 pts

Red flags

F-score 6 of 8
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹137 Cr +35.6% vs Jun 2025. Net profit ₹16 Cr +100.0%.
Against our estimate for Jun 2026: sales -9.8%, profit +35.9% beat. Our estimate for Sep 2026: sales Rs 171 Cr, profit Rs 16 Cr (how).

Activity

Compare
CompanyMcap (Cr)P/EROCE
Sun Pharmaceutical Industries Ltd447,47635.420.5 %
Divis Laboratories Ltd250,36384.022.0 %
Torrent Pharmaceuticals Ltd186,15283.415.2 %
Zydus Lifesciences Ltd119,75024.621.1 %
Cipla Ltd111,43031.115.5 %
Laurus Labs Ltd106,92897.817.8 %
Mankind Pharma Ltd105,12049.313.5 %
Dr Reddys Laboratories Ltd104,49432.413.0 %
Aurobindo Pharma Ltd97,68225.812.9 %
Lupin Ltd93,84015.829.9 %
Glenmark Pharmaceuticals Ltd68,90522.139.8 %
Alkem Laboratories Ltd62,77227.621.2 %
Biocon Ltd61,43984.53.61 %
Abbott India Ltd57,94935.944.8 %
Gland Pharma Ltd49,33343.115.1 %
No bulk or block deals on record.
Ex-dateActionFactor
2026-08-18Dividend - Rs 1.75 Per Share
2025-08-12Dividend - Rs 1.75 Per Share
2024-08-16Annual General Meeting/Dividend - Rs 1.75 Per Share
2023-08-18Annual General Meeting/Dividend - Rs 1.75 Per Share
DateTypeWhat it says
2026-09-25UpdatesDisclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEB...
2026-09-24Commencement of commercial pCommencement of commercial production/operations
2026-09-16Concall / analyst meetOutcome
2026-09-10Concall / analyst meetSchedule of meet
2026-08-27Shareholder meetingVoting results.
2026-08-25Shareholder meetingProceedings of undefined held on August 25, 2026
2026-08-20CorrigendumCorrigendum to the 45th Annual Report for the Financial Year 2025-2026
2026-08-17Investor PresentationInvestor Presentation
2026-08-12UpdatesBoard comments on fines levied by the Exchanges.
2026-08-12Integrated Filing- FinancialOutcome of Board Meeting
2026-08-12Board meeting outcomeNGL Fine-Chem Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-07-31Shareholder meetingNotice of Annual General Meeting to be held on August 25, 2026
2026-07-31Shareholder meetingNotice of undefined to be held on August 25, 2026
2026-06-03Disclosure under SEBI TakeovRajesh Lawande has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Ac...
2026-05-30Concall / analyst meetTranscript
2026-05-25Concall / analyst meetLink of Recording
2026-05-22Investor PresentationInvestor Presentation
2026-05-21Change in ManagementChange in Management
2026-05-21Record DateRecord date for the purpose of Dividend is 18-Aug-2026.
2026-05-21Board meeting outcomeNGL Fine-Chem Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-05-19Concall / analyst meetSchedule of meet
2026-03-13Credit Rating- RevisionCredit Rating- Revision
2026-02-10Investor PresentationInvestor Presentation
2026-02-03AppointmentAppointment of Shivam Gharat - Company Secretary as Company Secretary of the company w.e.f. February 03, 2026.
2026-02-03Board meeting outcomeNGL Fine-Chem Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Close to Close price movement greater than 100perc in previous 365 daysHigh low price variation greater than 150perc in previous 12 months

Quick answers

What is the market cap of NGL Fine Chem Ltd?

NGL Fine Chem Ltd (NGLFINE) has a market capitalisation of Rs 1,774 Cr. at the 2026-10-01 close.

What is the P/E ratio of NGL Fine Chem Ltd?

NGL Fine Chem Ltd trades at a P/E of 35.2 on trailing twelve-month profit, at the 2026-10-01 close.

What were NGL Fine Chem Ltd's latest quarterly results?

In the Jun 2026 quarter, NGL Fine Chem Ltd sales was Rs 137 Cr (+35.6% vs Jun 2025) and net profit was Rs 16 Cr.

What is the 52-week high and low of NGL Fine Chem Ltd?

The 52-week high is Rs 3,602.00 and the 52-week low is Rs 1,271.00.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03